Aytu Biopharma (AYTU) Debt Ratio (2011 - 2026)

Aytu Biopharma (AYTU) has 15 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.18, up 94.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (up 94.84% YoY), and the FY2025 annual result was 0.1, down 4.76% from the prior year.
• Debt Ratio grew to 0.18 in Q1 2026 per AYTU's latest filing, from 0.1 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.2 in Q3 2025 and troughed at 0.01 in Q1 2024.
• A 5-year average of 0.11 and a median of 0.11 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 1633.41% in 2022, then slumped 91.71% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.1 in 2022, then climbed by 17.94% to 0.12 in 2023, then declined by 16.46% to 0.1 in 2024, then slipped by 4.61% to 0.1 in 2025, then surged by 83.91% to 0.18 in 2026.
• Business Quant data shows AYTU's Debt Ratio at 0.18 in Q1 2026, 0.1 in Q4 2025, and 0.2 in Q3 2025.